TY - JOUR
T1 - Gazefinder as a clinical supplementary tool for discriminating between autism spectrum disorder and typical development in male adolescents and adults
AU - Fujioka, Toru
AU - Inohara, Keisuke
AU - Okamoto, Yuko
AU - Masuya, Yasuhiro
AU - Ishitobi, Makoto
AU - Saito, Daisuke N.
AU - Jung, Minyoung
AU - Arai, Sumiyoshi
AU - Matsumura, Yukiko
AU - Fujisawa, Takashi X.
AU - Narita, Kosuke
AU - Suzuki, Katsuaki
AU - Tsuchiya, Kenji J.
AU - Mori, Norio
AU - Katayama, Taiichi
AU - Sato, Makoto
AU - Munesue, Toshio
AU - Okazawa, Hidehiko
AU - Tomoda, Akemi
AU - Wada, Yuji
AU - Kosaka, Hirotaka
N1 - Funding Information:
Part of this research was the result of the project “Integrated Research on Neuropsychiatric Disorders” which was carried out under the Strategic Research Program for Brain Sciences from MEXT and AMED. This work was partly funded by the Center of Community from MEXT, Grants-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (25293248, 15K08093), Implementation-Support Program (Call for proposal Type) from the Japan Science and Technology Agency, and the Takeda Science Foundation.
Publisher Copyright:
© 2016 Fujioka et al.
PY - 2016
Y1 - 2016
N2 - Background: Gaze abnormality is a diagnostic criterion for autism spectrum disorder (ASD). However, few easy-to-use clinical tools exist to evaluate the unique eye-gaze patterns of ASD. Recently, we developed Gazefinder, an all-in-one eye-tracking system for early detection of ASD in toddlers. Because abnormal gaze patterns have been documented in various ASD age groups, we predicted that Gazefinder might also detect gaze abnormality in adolescents and adults. In this study, we tested whether Gazefinder could identify unique gaze patterns in adolescents and adults with ASD. Methods: We measured the percentage of eye fixation time allocated to particular objects depicted in movies (i.e., eyes and mouth in human face movies, upright and inverted biological motion in movies that presented these stimuli simultaneously, and people and geometry in movies that presented these stimuli simultaneously) by male adolescents and adults with ASD (N = 26) and age-matched males with typical development (TD; N = 35). We compared these percentages between the two groups (ASD and TD) and with scores on the social responsiveness scale (SRS). Further, we conducted discriminant analyses to determine if fixation times allocated to particular objects could be used to discriminate between individuals with and without ASD. Results: Compared with the TD group, the ASD group showed significantly less fixation time at locations of salient social information (i.e., eyes in the movie of human faces without lip movement and people in the movie of people and geometry), while there were no significant groupwise differences in the responses to movies of human faces with lip movement or biological motion. In a within-group correlation analysis, a few of the fixation-time items correlated with SRS, although most of them did not. No items significantly correlated with SRS in both ASD and TD groups. The percentage fixation times to eyes and people, which exhibited large effect sizes for the group difference, could differentiate ASD and TD with a sensitivity of 81.0 % and a specificity of 80.0 %. Conclusions: These findings suggest that Gazefinder is potentially a valuable and easy-to-use tool for objectively measuring unique gaze patterns and discriminating between ASD and TD in male adolescents and adults.
AB - Background: Gaze abnormality is a diagnostic criterion for autism spectrum disorder (ASD). However, few easy-to-use clinical tools exist to evaluate the unique eye-gaze patterns of ASD. Recently, we developed Gazefinder, an all-in-one eye-tracking system for early detection of ASD in toddlers. Because abnormal gaze patterns have been documented in various ASD age groups, we predicted that Gazefinder might also detect gaze abnormality in adolescents and adults. In this study, we tested whether Gazefinder could identify unique gaze patterns in adolescents and adults with ASD. Methods: We measured the percentage of eye fixation time allocated to particular objects depicted in movies (i.e., eyes and mouth in human face movies, upright and inverted biological motion in movies that presented these stimuli simultaneously, and people and geometry in movies that presented these stimuli simultaneously) by male adolescents and adults with ASD (N = 26) and age-matched males with typical development (TD; N = 35). We compared these percentages between the two groups (ASD and TD) and with scores on the social responsiveness scale (SRS). Further, we conducted discriminant analyses to determine if fixation times allocated to particular objects could be used to discriminate between individuals with and without ASD. Results: Compared with the TD group, the ASD group showed significantly less fixation time at locations of salient social information (i.e., eyes in the movie of human faces without lip movement and people in the movie of people and geometry), while there were no significant groupwise differences in the responses to movies of human faces with lip movement or biological motion. In a within-group correlation analysis, a few of the fixation-time items correlated with SRS, although most of them did not. No items significantly correlated with SRS in both ASD and TD groups. The percentage fixation times to eyes and people, which exhibited large effect sizes for the group difference, could differentiate ASD and TD with a sensitivity of 81.0 % and a specificity of 80.0 %. Conclusions: These findings suggest that Gazefinder is potentially a valuable and easy-to-use tool for objectively measuring unique gaze patterns and discriminating between ASD and TD in male adolescents and adults.
KW - Adolescent
KW - Adult
KW - Autism spectrum disorder
KW - Biological motion
KW - Discriminant analysis
KW - Eye-tracking
KW - Face
KW - Fixation
KW - Gaze abnormality
KW - Geometry
UR - http://www.scopus.com/inward/record.url?scp=85007564444&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85007564444&partnerID=8YFLogxK
U2 - 10.1186/s13229-016-0083-y
DO - 10.1186/s13229-016-0083-y
M3 - Article
C2 - 27011784
AN - SCOPUS:85007564444
SN - 2040-2392
VL - 7
JO - Molecular Autism
JF - Molecular Autism
IS - 1
M1 - 19
ER -